Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
12/01/1993 | EP0571536A1 Reagents and methods for identification of vaccines |
12/01/1993 | EP0571502A1 Pmn-derived cr3 modulator and uses thereof |
12/01/1993 | EP0571500A1 A high sulfur seed protein gene and method for increasing the sulfur amino acid content of plants |
12/01/1993 | EP0571442A1 Cytokine-induced protein, tsg-14, dna coding therefor and uses thereof |
12/01/1993 | EP0571417A1 Combination of igf-i and igfbp for anabolism. |
12/01/1993 | EP0571390A1 The delay, prevention and/or reversal of cell senescence |
12/01/1993 | EP0571387A1 A non-mitogenic competitive hgf antagonist |
12/01/1993 | EP0535161A4 Expression vectors containing the hiv -i(nef) gene to enhance replication efficiency |
12/01/1993 | EP0535154A4 Heterohybridomas producing human monoclonal antibodies to hiv-1 |
12/01/1993 | EP0502171A4 Composition for inducing granulocyte production or b cell production in peripheral blood |
12/01/1993 | EP0487591B1 Anticoagulant protein |
12/01/1993 | EP0329761B1 Hiv-1-related polypeptides, diagnostic systems and assay methods |
12/01/1993 | CN1079002A Chicken growth hormone gene and an expression thereof in E.coli |
11/30/1993 | US5266687 Inhibitors of angiogenin |
11/30/1993 | US5266685 Non-bitter protein hydrolyzates |
11/30/1993 | US5266683 Osteogenic proteins |
11/30/1993 | US5266561 Treatment of type 2 diabetes mellitus |
11/30/1993 | US5266491 DNA fragment and expression plasmid containing the DNA fragment |
11/30/1993 | US5266490 Mammalian expression vector |
11/30/1993 | US5266489 Recombinant herpesviruses, in particular for the production of vaccines, process for preparing them, plasmids produced during this process and vaccines obtained |
11/30/1993 | US5266483 Bacillus strain and insect pest controlling agent |
11/30/1993 | US5266477 Monoclonal antibodies which differentiate between native and modified porcine somatotropins |
11/30/1993 | US5266474 Balanced inducible transcription system |
11/30/1993 | US5266465 α-1-antichymotrypsin, analogues and methods of production |
11/30/1993 | US5266328 Prosthetics |
11/30/1993 | US5266327 Polyamides |
11/30/1993 | US5266317 Insect-specific paralytic neurotoxin genes for use in biological insect control: methods and compositions |
11/30/1993 | US5266313 Raccoon poxvirus as a gene expression and vaccine vector for genes of rabies virus and other organisms |
11/30/1993 | US5266311 Bovine interleukin-1α |
11/27/1993 | CA2096923A1 Synthesis of sialoconjugates |
11/25/1993 | WO1993023571A1 Human cell cycle checkpoint genes |
11/25/1993 | WO1993023569A1 Method and reagent for inhibiting viral replication |
11/25/1993 | WO1993023559A1 Alteration of the interaction of the cd4 t-cell receptor with an raf-1-related protein |
11/25/1993 | WO1993023550A2 Activation of oligomerizing receptors by using fused receptor ligands |
11/25/1993 | WO1993023549A2 Nucleic acid corresponding to a gene of chromosome 22 involved in recurrent chromosomal translocations associated with the development of cancerous tumors |
11/25/1993 | WO1993023548A2 METHOD OF DETECTING TISSUE-SPECIFIC FK506 BINDING PROTEIN MESSENGER RNAs AND USES THEREOF |
11/25/1993 | WO1993023544A1 Fusion protein from feline leukaemia virus gp70 as vaccine |
11/25/1993 | WO1993023543A1 Clostridium perfringens vaccines |
11/25/1993 | WO1993023542A1 Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
11/25/1993 | WO1993023541A1 Hepatocyte growth factor variants |
11/25/1993 | WO1993023540A2 Improved methods for the preparation of endotoxin-binding proteins |
11/25/1993 | WO1993023539A1 RETINOBLASTOMA-ASSOCIATED PROTEIN 1 cDNA |
11/25/1993 | WO1993023538A1 Isolated protein receptors, antibodies which bind thereto, nucleic acid sequence coding therefor, and uses thereof |
11/25/1993 | WO1993023537A1 Chimeric multivalent protein analogues and methods of use thereof |
11/25/1993 | WO1993023536A1 Sub-units of nmda receptors, process for producing the same and their use |
11/25/1993 | WO1993023535A1 Human 5ht-1b receptor (serotonin receptor), process for preparing the same and its uses |
11/25/1993 | WO1993023533A1 Anti-neoplastic in vivo drug screen |
11/25/1993 | WO1993023531A1 Methods and compositions modulating ribonucleic acid expression |
11/25/1993 | WO1993023526A1 A NOVEL RECEPTOR FOR α4 INTEGRINS AND METHODS BASED THEREON |
11/25/1993 | WO1993023434A2 Bpi-immunoglobulin fusion proteins |
11/25/1993 | WO1993023433A1 Methods and novel proteins associated with low renin syndrome |
11/25/1993 | WO1993023432A1 Soluble prion polypeptides, and methods for detecting and purifying thereof |
11/25/1993 | WO1993023431A1 Mutated steroid hormone receptors, methods for their use and molecular switch for gene therapy |
11/25/1993 | WO1993023430A1 Brain transcription factors, nucleic acids encoding same and uses thereof |
11/25/1993 | WO1993023429A1 Receptor-type tyrosine kinase-like molecules |
11/25/1993 | WO1993023428A1 Calcium channel blocking polypeptides from filistata hibernalis |
11/25/1993 | WO1993023427A1 Hiv protein epitopes immunologically homologous to hla |
11/25/1993 | WO1993023426A1 Monomer and dimer peptides, utilization as cytoprotector agents and preparation method |
11/25/1993 | WO1993023423A1 Canine coronavirus s gene and uses therefor |
11/25/1993 | WO1993023422A1 Compositions and methods for vaccination against coronaviruses |
11/25/1993 | WO1993023421A1 Universal coronavirus vaccine |
11/25/1993 | WO1993023379A1 Retroviral protease inhibitors |
11/25/1993 | WO1993023085A1 TECHNETIUM-99m LABELED PEPTIDES FOR THROMBUS IMAGING |
11/25/1993 | WO1993023081A1 Methods and agents for modulating immune response, and uses thereof |
11/25/1993 | WO1993023077A1 Vaccine for susceptible hosts against nonadapted parasites |
11/25/1993 | WO1993023068A1 Platelet derived growth factor antagonists |
11/25/1993 | WO1993023067A1 Igf-1 analogs |
11/25/1993 | WO1993023064A1 Compositions and methods for the prevention and treatment of thrombosis |
11/25/1993 | WO1993023063A1 Novel neutrophil inhibitors |
11/25/1993 | WO1993023062A1 Therapeutic conjugates of toxins and drugs |
11/25/1993 | WO1993020852A3 Macrocyclic chelating agents, chelates and conjugates thereof |
11/25/1993 | WO1993020203A3 Stability-enhanced variants of parathyroid hormone |
11/25/1993 | WO1993019178A3 Peptides useful for inducing tolerance |
11/25/1993 | WO1993016178A3 Sequences characteristic of human gene transcription product |
11/25/1993 | WO1992019743A3 Hcv genomic sequences for diagnostics and therapeutics |
11/25/1993 | CA2136312A1 Retroviral protease inhibitors |
11/25/1993 | CA2135905A1 Serotonin receptor, preparation and use thereof |
11/25/1993 | CA2135797A1 Brain transcription factors, nucleic acids encoding same and uses thereof |
11/25/1993 | CA2135749A1 Platelet derived growth factor antagonists |
11/25/1993 | CA2135748A1 Methods and agents for modulating immune response, and uses thereof |
11/25/1993 | CA2135646A1 Method and reagent for inhibiting viral replication |
11/25/1993 | CA2135512A1 Vaccine for susceptible hosts against nonadapted parasites |
11/25/1993 | CA2135471A1 Receptor-type tyrosine kinase-like molecules |
11/25/1993 | CA2135408A1 Chimeric multivalent protein analogues and methods of use thereof |
11/25/1993 | CA2135390A1 Novel neutrophil inhibitors |
11/25/1993 | CA2135306A1 Igf-1 analogs |
11/25/1993 | CA2135201A1 Universal coronavirus vaccine |
11/25/1993 | CA2134898A1 Compositions and methods for vaccination against coronaviruses |
11/25/1993 | CA2134326A1 Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections |
11/25/1993 | CA2118012A1 Hepatocyte growth factor variants |
11/25/1993 | CA2117893A1 Variant dimers for receptor activation |
11/25/1993 | CA2113437A1 Fusion protein from feline leukaemia virus gp70 as vaccine |
11/24/1993 | EP0571337A2 Process to purify proteins from cell systems |
11/24/1993 | EP0570916A2 Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same |
11/24/1993 | EP0570682A1 Synthetic lipid A glycoconjugate antigens for use in vaccines |
11/24/1993 | EP0570591A1 Process for producing sweetness inducer miraculin |
11/24/1993 | EP0570554A1 Monoclonal antibody and antibody components elicited to a polypeptide antigen ground state |
11/24/1993 | EP0570509A1 Htlv-i and htlv-ii peptide antigens and methods |
11/24/1993 | EP0570506A1 NOVEL $i(BACILLUS THURINGIENSIS) ISOLATES |
11/24/1993 | EP0570493A1 TECHNETIUM-99m LABELED POLYPEPTIDES FOR IMAGING |